Comparison of Efficacy on Healing, and Safety of Two Dressings Urgotul and TulleGras MS on Surgical Acute Wounds.

This is an interventional treatment trial for Surgical Acute Wounds focused on measuring non-inferiority, randomized, TulleGras, Urgotul, healing, surgical acute wounds, pain Read More

Inclusion Criteria:

• Male or female subject.
• Aged 18 to 75 years
• With a planned surgery:
• Of abdominal location
• Leading to an acute wound of a maximum total length ≤ 18 cm (corresponding to 2 investigational products)
• Absence of clinical sign suggestive of worsened wound (assessed only at the randomization visit)
• Followed-up in surgery department
• Written and signed informed consent obtained
• Affiliated to the French Social Security system or equivalent.

Exclusion Criteria:

• Underlying pathology that may interfere with wound healing in the opinion of the Investigator (human immunodeficiency virus [HIV], cancer, immunodeficiency disease, generalized infection, systemic disease ...). The presence of low-risk prostate cancer according to the Amico classification (1) (PSA<10 ng/mL and Gleason's score < 6 and clinical grade T1c ou T2a) or a grade T1 (a or b) N0M0 renal cancer which requires surgery without adjuvant therapy (radiotherapy, chemotherapy, hormonal therapy...), in a patient whose general condition is preserved without significant comorbidity or signs of malnutrition are not considered as a non- inclusion criteria
• Inadequately controlled diabetes (Glycosylated hemoglobin > 8%)
• Hypo or hyperthyroidism
• Intake of a systemic treatment with glucocorticoids or immunosuppressives
• Known allergy to one of study dressings components
• Participation in a clinical trial in the month prior to his/her inclusion in the study
• Pregnancy or breastfeeding or of childbearing potential and saying not to use contraception.